Anatomic Pathology Market By End User, By Region, Industry Analysis and Forecast, 2030
The global anatomic pathology market is set to record a market value of US$ 61.1 Mn by 2030, up from US$ 32.5 Mn in 2022, with an estimated growth rate of 8.2% CAGR, which indicates highly healthy market growth over the forecasted period (2022-2030). Anatomic pathology currently accounts for 0.2% share of the global pathology market. Increased cancer incidence and other illnesses is supporting the expansion of the anatomic pathology market.
Anatomic Pathology Product Demand Analysis (2015 to 2021) Vs Market Outlook (2022 to 2030)
Anatomic pathology is a medical speciality that focuses on identifying disorders through microscopic, macroscopic, biochemical, molecular, and immunological examinations of organs and tissues. Medical pathologists specialise in both anatomical and clinical pathology.
Anatomic pathology is concerned with the processing, evaluation, and diagnosis of surgical specimens by a physician with pathological diagnosis training. Anatomic pathology and clinical pathology are the two types of pathology.
Blood cell counts, urinalysis, blood glucose level assessments, coagulation investigations, and throat cultures are some of the more common test requests handled by clinical pathology. Hematology, immunology, microbiology, urinalysis, chemistry, and the blood bank are all aspects of pathology.
Breast, endocrine, gastrointestinal, head and neck, gynaecological, soft tissue, GU, dermatopathology, cytopathology, forensic pathology, neuropathology, and hematopathology are examples of anatomical pathology subspecialties utilised in surgical pathology. Autopsies and microscopic examinations of cells, tissues, and other specimens are commonly performed in hospitals to investigate the impact of disease on the human body.
Medical laboratory administrators are in charge of performing advanced laboratory tests on tissue or fluid samples, as well as ensuring that the tests are accurate and of high quality. Pathology is practised in community hospitals and university medical centres, where patients receive care, diagnostic services, and research all at the same time.
The anatomic pathology market expanded at a high CAGR of 9.3% from 2015 to 2021.
Increased use of biomarkers in clinical practice allows pathologists to determine disease causation at the molecular level, which aids clinical decision-making and improves patient outcomes. The market is being driven by an increasing reliance on biomarker-based pathology tests and treatments to investigate common malignancy and tumorigenesis.
The COVID-19 pandemic is propelling whole-slide imaging, digital pathology, and telepathology into the mainstream. Pathologists have been able to work remotely due to digital pathology, increasing their overall productivity and allowing them to catch up on case backlogs. Over the last few years, the adoption of these technologies has accelerated.
The COVID-19 pandemic has pushed adoption even further, which has a positive impact on market growth. Anatomic pathology market demand is predicted to progress at a CAGR of 8.2% from 2022 to 2030, with the global market expected to close in on a valuation of US$ 61.1 Mn by 2030.
Why are Sales of Anatomic Pathology Equipment Rising Rapidly?
“Increasing Cases of Chronic Diseases & Rising Investments in Healthcare Sector Driving Sales of Anatomic Pathology Instruments”
High incidence of cancer and other target diseases, the growing focus on customised care, and a large number of supporting programmes and training modules provided by the respective governments lead to the anatomic pathology market growth.
Because of the significant rise in modern pathology technology such as staining systems, gross imaging, and digital microscopes are becoming more widely used, with the potential to improve anatomic pathology practises to some extent. Digital imaging solutions additionally provide specificity and accuracy gains over traditional procedures, which enhances the total market's service adoption rate.
Furthermore, rising awareness and an increase in the patient pool in developing countries are propelling the market forward. Furthermore, the anatomic pathology market is being driven by an increase in healthcare expenditure and an increase in the use of biomarkers during illness diagnosis.
Which Obstacles are Anatomic Pathology Product & Service Providers Facing?
“Availability of Refurbished Devices Can Negatively Affect Demand for Anatomic Pathology Instruments”
Presence of refurbished anatomic pathology equipment is a major impediment to the anatomic pathology market expansion. Refurbished anatomic pathology devices such as tissue processors, staining systems, and microtomes are available from LabX (US), AL-TAR (US), Rankin Biomedical Corporation (US), and Swerdlick Medical Systems (US).
A lot of end users, primarily small and medium-sized laboratories, seek cost-effectiveness and choose refurbished systems, particularly in developing nations’ price-sensitive marketplaces. Given these considerations, demand for refurbished anatomic pathology tools is likely to rise in the next years, as these systems provide the same functionality as new equipment at a reduced cost.
For More Info: